Cost-Effectiveness Analysis of Branded Drugs With Market Demand and Insurance is a research paper published in Value in Health (2021). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: T32 AG051090
National Institutes of Health
Grant: 5T32AG051090-05
Training in Healthcare Financing, Organization and Delivery for Aging Populations
FWCI
0.70
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords